Wespac Advisors So Cal, LLC Neurocrine Biosciences Inc Transaction History

Wespac Advisors So Cal, LLC

  • $377 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 30, 2021
SELL
$87.57 - $119.4 $215,860 - $294,321
-2,465 Closed
0 $0
Q2 2018

Aug 03, 2018
BUY
$75.3 - $105.99 $185,614 - $261,265
2,465 New
2,465 $242,000
Q2 2018

Jul 13, 2018
SELL
$75.3 - $105.99 $50,074 - $70,483
-665 Closed
0 $0
Q4 2017

Feb 13, 2018
BUY
$58.53 - $77.59 $38,922 - $51,597
665
665 $51,000

Others Institutions Holding NBIX

# of Institutions
628
Shares Held
94.4M
Call Options Held
505K
Put Options Held
343K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Wespac Advisors So Cal, LLC Portfolio

Follow Wespac Advisors So Cal, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wespac Advisors So Cal, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wespac Advisors So Cal, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email